# US 2018/0023119 A1 · Single cell whole genome libraries and combinatorial indexing methods of making thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2018/0023119 A1
- Document ID: US20180023119A1
- Status: Published application
- Kind: A1
- Application number: 15/656,947
- Filed: 2017-07-21
- Published: 2018-01-25
- Earliest claimed: 2016-07-22
- Assignees: Illumina, Inc.; Oregon Health & Science University
- Applicants: Illumina, Inc.; Oregon Health & Science University
- Inventors: Andrew C. Adey; Sarah A. Vitak; Frank J. Steemers
- Web page: https://patentgrep.com/patent/US20180023119A1

## CPC

- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12N 15/1065: {Preparation or screening of tagged libraries, e.g. tagged microorganisms by STM-mutagenesis, tagged polynucleotides, gene tags}
- C12N 15/1093: {General methods of preparing gene libraries, not provided for in other subgroups}
- C12Q 1/6869: Methods for sequencing
- C12Q 1/6874: involving nucleic acid arrays, e.g. sequencing by hybridisation
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

Provided herein are methods for preparing a sequencing library that includes nucleic acids from a plurality of single cells. In one embodiment, the sequencing library includes whole genome nucleic acids from the plurality of single cells. In one embodiment, the method includes generating nucleosome-depleted nuclei by chemical treatment while maintaining integrity of the nuclei. Also provided herein are compositions, such as compositions that include chemically treated nucleosome-depleted isolated nuclei.

## Claims

### Claim 1

A method of preparing a sequencing library comprising nucleic acids from a plurality of single cells, the method comprising:
(a) providing isolated nuclei from a plurality of cells;
(b) subjecting the isolated nuclei to a chemical treatment to generate nucleosome-depleted nuclei, while maintaining integrity of the isolated nuclei;
(c) distributing subsets of the nucleosome-depleted nuclei into a first plurality of compartments and contacting each subset with a transposome complex, wherein the transposome complex in each compartment comprises a transposase and a first index sequence that is different from first index sequences in the other compartments;
(d) fragmenting nucleic acids in the subsets of nucleosome-depleted nuclei into a plurality of nucleic acid fragments and incorporating the first index sequences into at least one strand of the nucleic acid fragments to generate indexed nuclei comprising indexed nucleic acid fragments, wherein the indexed nucleic acid fragments remain attached to the transposases;
(e) combining the indexed nuclei to generate pooled indexed nuclei;
(f) distributing subsets of the pooled indexed nuclei into a second plurality of compartments;
(g) incorporating into the indexed nucleic acid fragments in each compartment a second index sequence to generate dual-index fragments, wherein the second index sequence in each compartment is different from second index sequences in the other compartments;
(h) combining the dual-index fragments, thereby producing a sequencing library comprising whole genome nucleic acids from the plurality of single cells.

### Claim 2 (depends on 1)

The method of claim 1, wherein the chemical treatment comprises a treatment with a chaotropic agent capable of disrupting nucleic acid-protein interactions.

### Claim 3 (depends on 2)

The method of claim 2, wherein the chaotropic agent comprises lithium 3,5-diiodosalicylic acid.

### Claim 4 (depends on 1)

The method of claim 1, wherein the chemical treatment comprises a treatment with a detergent capable of disrupting nucleic acid-protein interactions.

### Claim 5 (depends on 4)

The method of claim 4, wherein the detergent comprises sodium dodecyl sulfate (SDS).

### Claim 6 (depends on 5)

The method of claim 5, wherein the nuclei are treated with a cross-linking agent prior to step (b).

### Claim 7 (depends on 6)

The method of claim 6, wherein the cross-linking agent is formaldehyde.

### Claim 8 (depends on 7)

The method of claim 7, wherein the cross-linking by formaldehyde is reversed after step (f) and prior to step (g).

### Claim 9 (depends on 8)

The method of claim 8, wherein the transposases are disassociated from the indexed nucleic acid fragments prior to the reversal of the cross-linking.

### Claim 10 (depends on 9)

The method of claim 9, wherein the transposases are disassociated from the indexed nucleic acid fragments using sodium dodecyl sulfate (SDS).

### Claim 11 (depends on 1)

The method of claim 1, wherein the nuclei are treated with a restriction enzyme prior to step (d).

### Claim 12 (depends on 11)

The method of claim 11, wherein the nuclei are treated with a ligase after treatment with the restriction enzyme.

### Claim 13 (depends on 1)

The method of claim 1, wherein the subsets of the pooled indexed nuclei include at least 10 times fewer nuclei than the subsets of the nucleosome-depleted nuclei.

### Claim 14 (depends on 1)

The method of claim 1, wherein each of the transposome complexes comprises a transposon, each of the transposons comprising a transferred strand.

### Claim 15 (depends on 14)

The method of claim 14, wherein the transferred strand comprises the first index sequence and a first universal sequence.

### Claim 16 (depends on 15)

The method of claim 15, wherein the incorporation of the second index sequence in step (g) comprises contacting the indexed nucleic acid fragments in each compartment with a first universal primer and a second universal primer, each comprising an index sequence and each comprising a sequence identical to or complementary to a portion of the first universal sequence, and performing an exponential amplification reaction.

### Claim 17 (depends on 16)

The method of claim 16, wherein the index sequence of the first universal primer is the reverse complement of the index sequence of the second universal primer.

### Claim 18 (depends on 16)

The method of claim 16, wherein the first universal primer further comprises a first capture sequence and a first anchor sequence complementary to a universal sequence at the 3′ end of the dual-index fragments.

### Claim 19 (depends on 16)

The method of claim 16, wherein the second universal primer further comprises a second capture sequence and a second anchor sequence complementary to a universal sequence at the 5′ end of the dual-index fragments.

### Claim 20 (depends on 1)

The method of claim 1, further comprising sequencing of the dual-index fragments to determine the nucleotide sequence of nucleic acids from the plurality of single cells.

### Claim 21 (depends on 20)

The method of claim 20, further comprising:
providing a surface comprising a plurality of amplification sites,
wherein the amplification sites comprise at least two populations of attached single stranded capture oligonucleotides having a free 3′ end, and
contacting the surface comprising amplification sites with the dual-index fragments under conditions suitable to produce a plurality of amplification sites that each comprise a clonal population of amplicons from an individual dual-index fragment.

### Claim 22

A composition comprising chemically treated nucleosome-depleted isolated nuclei, wherein the isolated nuclei comprise indexed nucleic acid fragments.

### Claim 23 (depends on 22)

The composition of claim 22, wherein the isolated nuclei comprise non-natural cross-links.

### Claim 24 (depends on 22)

The composition of claim 22, wherein the composition comprises indexed nucleic acid fragments that terminate in a cleaved restriction site comprising an overhang.

### Claim 25 (depends on 22)

The composition of claim 22, wherein the isolated nuclei comprise rearranged genomic DNA.
